Lab Architecture

Spirited panel discussions at the 2005 Pacific Health Summit launched the creation of the Infectious Diseases/Pandemics Policy Lab. The goal of this Lab is to contribute research and support to saving lives and minimizing the economic impact of infectious diseases. Toward this end, the lab highlights best practices through targeted workshops, case studies, and briefings.

The lab is organized into two modules designed to tackle the distinct challenges posed by emerging infectious diseases such as avian flu and MDR-TB, as well as the continuing threats of TB, cholera, and other diseases. It acknowledges their common infrastructure, which can be employed toward creating an effective health systems response.


Key Meetings

Publications

Pandemic Flu Preparedness: How Far Have We Come in the Last Five Years?

How will recent developments in pandemic flu preparedness better equip high-risk countries, such as those in Southeast Asia, for future outbreaks? Dr. Peter Clevestig and Rachel Irwin of SIPRI address this and more, including the WHO’s new Pandemic Influenza Preparedness Framework and the interplay between human and animal health.

2009 Pacific Health Summit – Multidrug Resistant Tuberculosis: Overcoming Global Resistance

At the fifth annual Summit in June 2009, top leaders tackled how science, industry, and policy can accelerate the uptake of innovation to address the emerging global health threat of multidrug-resistant TB.

2007 Pacific Health Summit - Pandemics: Working Together for an Effective and Equitable Response

Participants discussed the challenges presented by avian flu and other emerging communicable and non-communicable pandemics. At the top of the agenda were issues such as the building of vaccine manufacturing capacity and the establishment of financial mechanisms to increase developing countries' access to pandemic and pre-pandemic influenza vaccines.

Show More Publications

Online Resources

Research Pages
Comprehensive resources for those interested in the history and evolving developments in pandemic influenza vaccines and tuberculosis, which provides background research, international policy resources, and key organizations.

Top